Key players such as Pharnext and others are developing therapies to enhance treatment modalities in the Charcot Marie Tooth market

 Breaking News
  • No posts were found

Key players such as Pharnext and others are developing therapies to enhance treatment modalities in the Charcot Marie Tooth market

September 21
20:12 2021
Key players such as Pharnext and others are developing therapies to enhance treatment modalities in the Charcot Marie Tooth market
Charcot Marie Tooth Market
DelveIsight’s Charcot Marie Tooth market report offers detailed information on the Charcot Marie Tooth disease, historical and epidemiology forecasted epidemiology, and Charcot Marie Tooth market trends in the 7MM.

DelveIsight’s Charcot Marie Tooth market report offers detailed information on the Charcot Marie Tooth disease, historical and epidemiology forecasted epidemiology, and Charcot Marie Tooth market trends in the 7MM (the US, EU5 (France, Spain, Italy, the UK, and Germany), and Japan).

Key Takeaways from the Charcot Marie Tooth Market Report

  • As per DelveInsight’s estimate, the total Charcot Marie Tooth prevalence was 263,835 in the 7MM in 2020, which is expected to rise even more by 2030

  • Among the EU5 countries, France has the highest Charcot Marie Tooth diagnosed prevalence while Spain had the least in 2020.

  • As per DelveInsight’s Charcot Marie Tooth epidemiology analysis, males had the highest number of CMT cases than females in the 7MM in 2020.

  • The Charcot Marie Tooth market size was found to be USD 55 million in the 7MM in 2020. 

  • Leading pharmaceutical companies such as Pharnext and others are working on their lead assets to improve the Charcot Marie Tooth treatment landscape.

  • Key CMT therapies in the pipeline include PXT3003 and others.

  • PXT3003, a novel, synergistic, low-dose fixed combination of baclofen (a muscle relaxant), naltrexone (an opioid antagonist), and sorbitol (a laxative) given twice daily as an oral solution, is being developed by Pharnext. It was developed using Pharnext’s R&D platform, Pleotherapy, and has Orphan Drug Designation in the EU and the US.

Request a sample to learn more about the CMT treatment landscape @ Charcot Marie Tooth Market Forecast

Charcot Marie Tooth Overview

Charcot Marie Tooth (CMT) is a disease of the peripheral nerves that control muscles. It is a group of genetically diverse disorders that affect the motor and peripheral sensory nerves, causing muscle weakness, atrophy, and sensory loss.

Charcot Marie Tooth Epidemiology Segmentation

The Charcot Marie Tooth report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:

  • Charcot Marie Tooth Total Prevalent Cases

  • Charcot Marie Tooth Diagnosed Prevalent Cases

  • Charcot Marie Tooth Gender-Specific Diagnosed Prevalent Cases

  • Charcot Marie Tooth Age-Specific Diagnosed Prevalent Cases

  • Charcot Marie Tooth Type-Specific Diagnosed Prevalent Cases

Charcot Marie Tooth Therapeutics Market

Charcot Marie Tooth has no cure and no approved therapies. The current CMT therapeutic market is based on supportive and symptomatic management, such as occupational therapies, physiotherapy, ankle-foot orthoses (AFO), and shoe inserts. Physiotherapy is the most commonly used aid, followed by foot care and occupational therapy.

Charcot Marie Tooth Market Outlook

Increased awareness of this distinct histology has resulted in developing drugs specific to Charcot Marie Tooth (CMT). It has begun to shed light on the similarities and possible differences. These factors and the anticipated introduction of new therapies such as PXT3003 will drive the CMT market during the forecast period (2021–2030).

Find out more about the market trends @ Charcot Marie Tooth Market Analysis

Charcot Marie Tooth Pipeline Therapies and Key Companies

  • PXT3003: Pharnext

Charcot Marie Tooth Market Drivers

  • Potential therapies 

  • Awareness and knowledge

  • Increasing prevalence

  • Limited competition for upcoming therapies

Charcot Marie Tooth Market Barriers

  • Challenging disease in terms of diagnosis and management

  • High diagnostic cost

  • Lack of robust pipeline

  • High disease burden

Scope for the Report

Coverage: 7MM (the US, EU5 (the UK, Germany, Italy, Spain, and France) and Japan)

Study Period: 2018-30

Charcot Marie Tooth Key Companies: Pharnext, among others. 

Charcot Marie Tooth Key Pipeline Therapies: PXT3003, and others.

Charcot Marie Tooth Segmentation: By Geography, By Charcot Marie Tooth therapies

Analysis: Comparative and conjoint analysis of Charcot Marie Tooth emerging therapies

Tools Used: SWOT Analysis

Case Studies

KOL’s Views

Analyst’s Views

Table of Contents

1.

Key Insights

2.

Report Introduction

3.

Charcot–Marie–Tooth (CMT) Market Overview at a Glance

4.

Charcot–Marie–Tooth (CMT) Market: Future Perspective

5.

Executive Summary of Charcot–Marie–Tooth (CMT)

6.

Key Events

7.

Charcot–Marie–Tooth: Disease Background and Overview

8.

CMT Epidemiology and Patient Population

9.

Patient Journey

10.

Organizations contributing towards Charcot Marie Tooth Disease

11.

CMT Emerging Drugs

12.

Charcot–Marie–Tooth (CMT): Seven Major Market Analysis

13.

KOL Views

14.

CMT Market Drivers

15.

CMT Market Barriers

16.

SWOT Analysis

17.

CMT Unmet Needs

18.

CMT Reimbursement and Market Access

19.

Appendix

20.

DelveInsight Capabilities

21.

Disclaimer

22.

About DelveInsight

For rich insights into Healthcare and Pharmaceutical News, visit Pharma, Healthcare, and Biotech Blog Posts

Related Reports

Dravet Syndrome Market

Get a comprehensive analysis of Dravet Syndrome pipeline therapies and key companies such as Biocodex, GW Pharmaceuticals, Zogenix, Ovid Therapeutics, PTC Therapeutics, among others.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/